Jorge E Gomez, MD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:Hematology-Oncology, Cancer (Oncology)
MD, Universidad De Caldas
Residency, Internal Medicine, Pennsylvania Hospital
Fellowship, Hematology/Oncology, New York University School of Medicine
- A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
The purpose of this study is to find out what effects, good and/or bad, one of the following treatments has on people with locally advanced, non-operable lung cancer with the specific gene alterations, EGFR mutation and/or ALK rearrangement.